Malleability and Versatility of Cytochrome P450 Active Sites Studied by Molecular Simulations

被引:15
|
作者
Oostenbrink, Chris [1 ,2 ]
de Ruiter, Anita [1 ]
Hritz, Jozef [3 ]
Vermeulen, Nico [2 ]
机构
[1] Univ Nat Resources & Life Sci, Inst Mol Modeling & Simulat, A-1190 Vienna, Austria
[2] Leiden Amsterdam Ctr Drug Res, Div Mol & Computat Toxicol, NL-1081 HV Amsterdam, Netherlands
[3] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA
基金
欧洲研究理事会;
关键词
Site of metabolism prediction; protein flexibility; molecular docking; molecular dynamics simulations; replica exchange; BINDING-AFFINITY; FREE-ENERGY; COMPUTATIONAL PREDICTION; SUBSTRATES ENTER; PRODUCTS EXIT; IN-SILICO; DYNAMICS; METABOLISM; P450; 2D6;
D O I
10.2174/138920012798918453
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As the most important phase I drug metabolizing enzymes, the human Cytochromes P450 display an enormous versatility in the molecular structures of possible substrates. Individual isoforms may preferentially bind specific classes of molecules, but also within these classes, some isoforms show remarkable levels of promiscuity. In this work, we try to link this promiscuity to the versatility and malleability of the active site at the hand of examples from our own work. Mainly focusing on the flexibility of protein structures and the presence or absence of water molecules, we establish molecular reasons for observed promiscuity, determine the relevant factors to take into account when predicting binding poses and rationalize the role of individual interactions in the process of ligand binding. A high level of active site flexibility does not only allow for the binding of a large variety of substrates and inhibitors, but also appears to be important to facilitate ligand binding and unbinding.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 50 条
  • [21] Molecular dynamics simulations give insight into the conformational change, complex formation, and electron transfer pathway for cytochrome P450 reductase
    Suendermann, Axel
    Oostenbrink, Chris
    PROTEIN SCIENCE, 2013, 22 (09) : 1183 - 1195
  • [22] Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli
    Quehl, Paul
    Hollender, Joel
    Schueuermann, Jan
    Brossette, Tatjana
    Maas, Ruth
    Jose, Joachim
    MICROBIAL CELL FACTORIES, 2016, 15
  • [23] Mechanism of the plant cytochrome P450 for herbicide resistance: a modelling study
    Li, Qinfan
    Fang, Yupeng
    Li, Xiuxiu
    Zhang, Hong
    Liu, Mengmeng
    Yang, Huibin
    Kang, Zhuo
    Li, Yan
    Wang, Yonghua
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2013, 28 (06) : 1182 - 1191
  • [24] Cannabinoids and Cytochrome P450 Interactions
    Zendulka, Ondrej
    Dovrtelova, Gabriela
    Noskova, Kristyna
    Turjap, Miroslav
    Sulcova, Alexandra
    Hanus, Lumir
    Jurica, Jan
    CURRENT DRUG METABOLISM, 2016, 17 (03) : 206 - 226
  • [25] Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes
    Raunio, Hannu
    Kuusisto, Mira
    Juvonen, Risto O.
    Pentikainen, Olli T.
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [26] Methoxyflavone inhibitors of cytochrome P450
    McKendall, Michael
    Smith, Tasha
    Anh, Kien
    Ellis, Jamie
    McGee, Terri
    Foroozesh, Maryam
    Zhu, Naijue
    Stevens, Cheryl L. Klein
    JOURNAL OF CHEMICAL CRYSTALLOGRAPHY, 2008, 38 (04) : 231 - 237
  • [27] Keeping the spotlight on cytochrome P450
    Shalan, Hadil
    Kato, Mallory
    Cheruzel, Lionel
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2018, 1866 (01): : 80 - 87
  • [28] Porcine cytochrome P450 and metabolism
    Skaanild, Mette Tingleff
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (11) : 1421 - 1427
  • [29] Practical Application of Cytochrome P450
    Sakaki, Toshiyuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (06) : 844 - 849
  • [30] Cytochrome P450 and radiopharmaceutical metabolism
    Giron, M. C.
    Portolan, S.
    Bin, A.
    Mazzi, U.
    Cutler, C. S.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 52 (03) : 254 - 266